-
Adipose-Neural Axis and Cardiac Arrhythmia
2026-10-07
Fan et al. develop a stem cell-based coculture model linking epicardial adipose tissue, sympathetic neurons, and cardiomyocytes to arrhythmogenesis through a leptin–NPY–Y1R pathway. The study provides mechanistic evidence for adipose-neural signaling in cardiac electrical dysfunction while also defining important boundaries for translating the model to patient care or Y2 receptor research.
-
KX2-391 Dihydrochloride: Mechanism & Evidence
2026-10-07
KX2-391 dihydrochloride, also called Tirbanibulin dihydrochloride, is a dual-action research compound associated with non-ATP-competitive Src inhibition and tubulin polymerization inhibition. Evidence for HBV transcription and botulinum neurotoxin A activity is reported in product documentation and should be interpreted separately from the primary oncology pharmacology paper.
-
3-Deazaneplanocin A Hydrochloride: 5 Questions
2026-10-06
A source-grounded overview of DZNep, PRC2-associated chromatin biology, and what a recent human pluripotent stem cell study does—and does not—show about chromatin restoration.
-
Viral RIPK3 Degradation Shapes Inflammation
2026-10-05
Liu et al. identified a conserved orthopoxviral strategy in which a viral inducer of RIPK3 degradation recruits host SCF machinery to promote RIPK3 ubiquitination and proteasomal turnover. The study connects this mechanism to necroptosis, virus-induced inflammation, replication, and disease severity, while also showing how viral gene loss can alter pathogen–host interactions.
-
CB-5083 and p97 in Proteostasis Research
2026-10-04
CB-5083 is a research-stage p97 inhibitor used to study protein quality control, proteotoxic stress, and cancer biology. This overview compares supplier-reported biochemical and oncology findings with the peer-reviewed evidence linking p97 to HRD1-SEL1L-regulated stress-granule homeostasis, while emphasizing mechanistic uncertainty, model limitations, and boundaries of translational interpretation.
-
NMDAR–Cav2.1 Recruitment in PV Interneuron Maturation
2026-10-03
Singh et al. show that developmental NMDAR signaling in neocortical parvalbumin interneurons is required for mature Cav2.1-dependent GABA release, not merely for establishing intrinsic excitability. The study links early Grin1 loss to impaired inhibitory transmission and provides a mechanistic framework for understanding how altered fast-spiking interneuron development could affect cortical excitation–inhibition balance.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-10-02
This study established Drosophila Schneider 2 cells as an invertebrate model for examining Spiroplasma eriocheiris invasion. Its inhibitor-based experiments identify clathrin-mediated endocytosis and macropinocytosis as major entry routes and show that both actin filaments and microtubules support intracellular infection.
-
SU5416 Workflow for VEGFR2 Angiogenesis Assays
2026-10-01
SU5416 (Semaxanib) enables mechanism-focused studies of VEGFR2 signaling, endothelial proliferation, and VEGF-induced angiogenesis inhibition. This practical workflow also shows how to connect vascular-cell assays with pulmonary hypertension modeling while separating established evidence from hypothesis-generating applications.
-
Pomalidomide (CC-4047) Research Workflows
2026-10-01
Build genotype-aware multiple myeloma assays with Pomalidomide (CC-4047), from DMSO stock preparation and cytokine profiling to viability and HbF readouts. This workflow connects tumor microenvironment modulation with the mutational heterogeneity highlighted in human myeloma cell-line research.
-
CDC42 Polarity and Intestinal Stem Cell Fate
2026-09-30
The reference study identifies CDC42-dependent epithelial polarity as an upstream regulator of the intestinal stem cell to transit-amplifying cell transition. Its genetic and pharmacological experiments place YAP/TAZ–Ereg–mTOR signaling downstream of polarity control and show that restoring cell-fate balance does not necessarily restore epithelial architecture.
-
Drying Strategies for mRNA–Lipid Nanoparticles
2026-09-30
Zhen and colleagues provide a comparative review of freeze-drying and emerging drying technologies for mRNA and other nucleic acid lipid nanoparticles. The analysis shows that solid-state processing could reduce dependence on ultra-low-temperature storage, while emphasizing that cargo structure, formulation composition, drying stresses, reconstitution, and administration route must be evaluated together.
-
Bivalent mRNA–LNP Vaccine Protects Chickens Against H5/H7
2026-09-29
Wei et al. developed a nucleoside-modified mRNA–LNP vaccine encoding H5N1 and H7N9 hemagglutinins and evaluated it in SPF chickens. High-dose vaccination produced strong neutralizing responses, broad protection against lethal homologous and heterologous challenges, reduced viral replication and shedding, and transcriptomic evidence of Th1-associated immune activation.
-
Ridaforolimus at the mTOR–Senescence Interface
2026-09-29
Ridaforolimus (Deforolimus, MK-8669) offers a mechanistically anchored way to study mTOR signaling, cancer-cell growth, angiogenesis, and the unresolved boundary between cytostasis and senolysis. This thought-leadership guide connects its pharmacology with machine-learning-enabled senolytic discovery and outlines a translational validation strategy.
-
METTL3–COL5A2 Axis Suppresses Gastric Cancer Ferroptosis
2026-09-28
A 2026 study links METTL3-driven m6A modification to stabilization of COL5A2 mRNA by IGF2BP3, connecting RNA regulation with FAK/MAPK/ERK signaling and ferroptosis resistance in gastric cancer models. Its cell and xenograft findings identify a testable pathway, while the use of PF-573228 provides pharmacological support for FAK involvement rather than evidence of a treatment-ready strategy.
-
Amplex Red for Redox Assays and Wetland Insights
2026-09-27
Amplex Red converts hydrogen peroxide into a fluorescent readout, making it useful for oxidase activity and extracellular ROS workflows when paired with careful controls. This guide connects assay design to a mangrove carbon study while clarifying what fluorescence can—and cannot—say about iron-driven soil processes.